dia 2022

Greenphire talks clinical trial challenges at DIA Global Annual Meeting

By Jenni Spinner contact

- Last updated on GMT

(sesame/iStock via Getty Images Plus)
(sesame/iStock via Getty Images Plus)

Related tags: DIA, Greenphire, Clinical trials, Patient recruitment, Patient centricity, Clinical research

The trial financial management company outlined a range of solutions designed to help trial teams get a handle on budgeting, patient reimbursement, and more.

Greenphire, a company centered on financial lifecycle management technology for clinical studies, discussed its range of offerings aimed at helping clinical research operations better streamline their studies. For example, its EnvisiX technology, first launched two years ago, is intended to streamline the budgeting process via access to up-to-date, fair-market-value data for clinical trials around the globe; according to the company, contract research organizations (CROs) in North America, Europe, Latin America, and Asia, have seen improvements in workflow, collaboration, and transparency.

Clareece West, executive vice president for commercial operations, Linical

Linical (a full-spectrum, multinational CRO) was among EnvisiX’s early adopters. Clareece West, executive vice president for commercial operations at Linical, said, “We are excited to partner with Greenphire, enabling access to the most robust and contemporary investigator grant negotiated actuals data in the industry. This data, along with the ease of building a budget through a simple and flexible tool, brings considerable value to our clients’ clinical development programs​."

Ashley Baxter, Greenphire’s clinical pricing analyst, presented a session at DIA, “Optimizing Study Budgeting and Access to Industry Indicative FMV Data to Accelerate Trial Timelines​” on June 22.

Ashley Baxter, clinical pricing analyst, Greenphire

Regardless of study size or resources of the sponsor initiating a study, building and negotiating an appropriate budget continues to be one of the most complex, time-consuming, and costly aspects of a clinical trial​,” Baxter said. “I am honored to share how tools like Greenphire’s EnvisiX, are able to optimize and simplify the process through an intuitive workflow and access to real-time FMV data.​”


Related news

Show more

Related products

show more

Using SDTM, ADaM, and SEND

Using SDTM, ADaM, and SEND

Formedix | 09-Nov-2022 | Technical / White Paper

This article gives an overview of SDTM, ADaM, SEND and ARM, and discusses how these CDISC standards fit in with the wider clinical trial process, and how...

How to design an effective CRF

How to design an effective CRF

Formedix | 10-Oct-2022 | Technical / White Paper

CRFs and eCRFs are used for gathering patient data during clinical trials. They play a crucial role in helping to assess the safety and efficacy of clinical...

The Complexities of Ophthalmic Drug Development

The Complexities of Ophthalmic Drug Development

Altasciences | 04-Oct-2022 | Technical / White Paper

Ophthalmic drug development comes with a unique set of challenges that can be mitigated by working with an end-to-end solution provider with regulatory...

Because When It's On the Line... Capability Matters.

Because When It's On the Line... Capability Matters.

Baxter BioPharma Solutions | 01-Oct-2022 | Product Brochure

Baxter’s BioPharma Solutions business supports leading pharmaceutical companies in meeting their commercialization objectives by providing scientific expertise,...

Related suppliers

Follow us


View more